D.Western Therapeutics Institute, Inc. Stock: price and insider trades · Japan
株式会社デ・ウエスタン・セラピテクス研究所
D.Western Therapeutics Institute, Inc.: what insiders have been doing
D.Western Therapeutics Institute, Inc. belongs to the Health Care sector. Filings by its managers are published through EDINET (Japan FSA). 3 insiders have disclosed 7 filings since 5 November 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Insider buying of D.Western Therapeutics Institute, Inc. has been absent for the past year. Filings reach the EDINET (Japan FSA) feed a median of 7 days after the trade. This delay matters because a trade only becomes useful information once it is public.
Compared with its exchange (3,220 companies, median 3 filings), a count of 7 filings is above the norm. Since 2022, the database holds no purchases and 32 sales by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- ShareXTKSEDINET:S100ZC5F
- 100.0% of flowShareXTKSEDINET:S100Z74R
- 48.0% of flowShareXTKSEDINET:S100Z1Z2
- 5,130,600 shares50.0% of flowShareXTKSEDINET:S100Y1N2
- 5,012,100 shares50.0% of flowShareXTKSEDINET:S100Y26W
- 52.0% of flowShareXTKSEDINET:S100XHOQ
- ShareXTKSEDINET:S100X84O
- ShareXTKSEDINET:S100WW0N
- 5.5% of flowShareXTKSEDINET:S100WSYM
- 9.4% of flowShareXTKSEDINET:S100WRB8
- 10.4% of flowShareXTKSEDINET:S100WOFJ
- 11.3% of flowShareXTKSEDINET:S100WMQR
- 13.9% of flowShareXTKSEDINET:S100WMGY
- 14.9% of flowShareXTKSEDINET:S100WKVI
- 16.4% of flowShareXTKSEDINET:S100WJIU
- 18.2% of flowShareXTKSEDINET:S100WH40
- 1.9% of flowShareXTKSEDINET:S100V70Q
- 2.8% of flowShareXTKSEDINET:S100V6TF
- 4.6% of flowShareXTKSEDINET:S100UW9R
- 5.6% of flowShareXTKSEDINET:S100UV85
- 5.6% of flowShareXTKSEDINET:S100UUIV
- 6.7% of flowShareXTKSEDINET:S100UTOI
- 10.2% of flowShareXTKSEDINET:S100UASP
- 10.6% of flowShareXTKSEDINET:S100U8ZR
- 11.1% of flowShareXTKSEDINET:S100U33Z
25 of 71 declarations
About D.Western Therapeutics Institute, Inc.
De Western Therapeutics Institute, Inc. is a Japanese company focused on research and development of innovative therapies in the health and pharmaceutical sector. It aims to create therapeutic solutions for various diseases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
